Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zonisamide SR shows improved tolerability over zonisamide IR

June 12, 2007

Nebido maintains clinically therapeutic testosterone levels in hypogonadal men

June 12, 2007

Phase I study begins for AIR parathyroid hormone

June 12, 2007

Androxal shows significant positive effects in men with secondary hypogonadism

June 11, 2007

Phosphagenics awarded AusIndustry grant for TPM-02

June 11, 2007

GlaxoSmithKline and Biovitrum terminate program in obesity

June 11, 2007

New ghrelin receptor ligands show antiobesity properties by increasing energy expenditure

June 11, 2007

New therapeutic agents for metabolic disorders reported in recent patents

June 11, 2007

Amgen to acquire Alantos

June 8, 2007

SLx-4090 studied in new phase IIa for dyslipidemia

June 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...